Menu Back toSession 5 Track 3: Novel and Emerging Technologies

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 5 Track 3: Novel and Emerging Technologies

Session Chair(s)

Paul Minne, PharmD, RPh

Director, MSL Team
Neurocrine Biosciences, United States

Kay Uttech, PharmD, MA, RPh

VP, Strategic Initiatives
Indegene, United States

This session will incorporate real life cases and panel discussions showing how technology can turn a problem into a solution. We will highlight uses of new technologies and discuss ways to potentially incorporate them into producing results for Medical Affairs teams. Emerging technology applications into medical affairs best practices and implications for organizations change will be the center of the dialogue.

Learning Objective : At the conclusion of this session, participants should be able to:

Interpret digital literacy to compare and contrast the impact that technology has on Medical Affairs

Apply technology solutions to common issues and landscape changes occurring in industry

Assess the potential future benefits of virtual reality, artificial intelligence, and machine learning and their implications for Medical Affairs

Speaker(s)

What Problem are we Solving?

Chris Wasden, EdD, MBA

Head of Pharma Specialty Solutions and Corporate Strategy
Happify Health, United States

Tools to Change Medical Affairs

Colin Baughman, MBA

Managing Partner and Founder
True North Solutions Inc., United States

Field Medical Perspectives

Christy Cheung, PharmD, RPh

Lead, Digital Innovation & Transformation
Sanofi, Canada

Contact us